Ekso Bionics Holdings, Inc. Appoints William Shaw as Chief Commercial Officer
May 06, 2019 at 08:11 am EDT
Share
Ekso Bionics Holdings, Inc. appointed William Shaw as Chief Commercial Officer of the company, effective May 6, 2019. He brings more than 15 years of medical device sales and leadership experience to the company. From July 2014 until joining the company, he worked in different roles at Zimmer Biomet Robotics, serving most recently as the Commercial Vice President of Americas for the ROSA® Robotics Platform and Zimmer Biomet mymobility™. In that role, his responsibilities included managing new strategic business units and building new corporate training organization for business units. From February 2014 to July 2014, he was a regional sales director for Salesforce.com, where he managed the Central Region Small Business Team.
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
EKSO BIONICS HOLDINGS, INC. 
